Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jeyachitra Amirdhanayagam"'
Autor:
Naveen Kumar, Mohini Guleria, Avik Chakraborty, Jeyachitra Amirdhanayagam, Trupti Upadhye Bannore, Archana Damle, Haladhar D. Sarma, Tapas Das
Publikováno v:
Drug Development Research. 83:1777-1790
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ada546761946c85fd581d81d99b422
https://doi.org/10.1002/ddr.21996
https://doi.org/10.1002/ddr.21996
Autor:
Ajit Nimmagadda, Parthasarathy Ravi, Tapas Das, Mohini Guleria, Ramya Priya Rallapeta, Tekchand Kalawat, V S Krishnamohan, Jeyachitra Amirdhanayagam, Sailaja Patri, Haladhar Dev Sarma
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International, Vol 2021 (2021)
Objective. In the recent time, endoradionuclide therapy for metastatic castration-resistant prostate carcinoma employing 177Lu-PSMA-617 has yielded encouraging results and several clinical trials with the agent are currently ongoing. Routine preparat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f749d97d7a9961c452b4c9d29dd92ec
https://doi.org/10.1155/2021/1555712
https://doi.org/10.1155/2021/1555712
Publikováno v:
Journal of Photochemistry and Photobiology A: Chemistry. 441:114754
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f50d4cfd54682f6c11d43438d0d4767a
https://doi.org/10.1016/j.jphotochem.2023.114754
https://doi.org/10.1016/j.jphotochem.2023.114754
Autor:
Naveen, Kumar, Mohini, Guleria, Avik, Chakraborty, Jeyachitra, Amirdhanayagam, Trupti Upadhye, Bannore, Archana, Damle, Haladhar D, Sarma, Tapas, Das
Publikováno v:
Drug development researchREFERENCES. 83(8)
The objective of the present work is to evaluate the ability of the radiolabeled PAMAM dendrimers (polyamidoamine) towards facilitating the delivery of an in-house synthesized porphyrin derivative in the tumorous lesions to evaluate their candidature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de17e74af9aba352fc4ddc6b76d0bbf0
https://pubmed.ncbi.nlm.nih.gov/36112735
https://pubmed.ncbi.nlm.nih.gov/36112735
Autor:
Haladhar Dev Sarma, Jeyachitra Amirdhanayagam, Venkatesh Rangarajan, Mohini Guleria, Ashutosh Dash, Tapas Das, Rohit Sharma
Publikováno v:
RSC Medicinal Chemistry. 12:263-277
Trastuzumab (Herceptin®) is an approved immunotherapeutic agent used for the treatment of metastatic breast cancer over-expressing HER2 antigen receptors. The aim of the present work is to standardize the formulation protocol of [177Lu]Lu-trastuzuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb2b522ec7c13edb3c326b326d04aa8a
https://doi.org/10.1039/d0md00319k
https://doi.org/10.1039/d0md00319k
Autor:
Mohini Guleria, Shishu K. Suman, Naveen Kumar, Amit K. Sharma, Jeyachitra Amirdhanayagam, Haladhar D. Sarma, Drishty Satpati, Tapas Das
Publikováno v:
RSC medicinal chemistry. 13(11)
Cell penetrating peptides (CPPs) are known to possess a unique capacity to penetrate biological membranes and translocate various molecules into the cells. Therefore, porphyrin-CPP conjugates could be envisaged to boost the intracellular delivery of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab45ce2c55e6754d6dd5c30b1a31f493
https://pubmed.ncbi.nlm.nih.gov/36439980
https://pubmed.ncbi.nlm.nih.gov/36439980
Autor:
Naveen Kumar, Shishu Suman, Mohini Guleria, Jeyachitra Amirdhanayagam, Haladhar D Sarma, Tapas Das
Publikováno v:
Nuclear Medicine and Biology. :S183-S184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58a732ac2584033718541b47a2fd8694
https://doi.org/10.1016/s0969-8051(22)00383-3
https://doi.org/10.1016/s0969-8051(22)00383-3
Publikováno v:
Nuclear Medicine and Biology. :31-40
Introduction [177Lu]Lu-DOTA-Ahx-Lys40-Exendin-4 ([177Lu]Lu-DOTA-Exendin-4) is a potential agent for radiotherapy of insulinomas owing to its specificity towards GLP-1 (Glucagon like peptide-1) receptors over-expressed on such cancers. The objective o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68bbe56862dc3961907577faa26386b7
https://doi.org/10.1016/j.nucmedbio.2019.11.003
https://doi.org/10.1016/j.nucmedbio.2019.11.003
Autor:
Jeyachitra Amirdhanayagam, Ashutosh Dash, Ajit Sugunan Shinto, Haladhar Dev Sarma, Arun Pandian, Tapas Das, Koramadai Karuppuswamy Kamaleshwaran, Mohini Guleria
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 34:67-75
Purpose: 68Ga-BPAMD has recently emerged as one of the preferred radiopharmaceuticals for imaging of bone lesions due to its ability to produce high-resolution images and uncomplicated ava...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a44036f47c6a1232c0ad58709e500e8
https://doi.org/10.1089/cbr.2018.2605
https://doi.org/10.1089/cbr.2018.2605
Autor:
Tapas Das, Kusum Vats, Mohini Guleria, Jeyachitra Amirdhanayagam, Haladhar Dev Sarma, Ashutosh Dash, Anupam Mathur
Publikováno v:
MedChemComm. 10:606-615
Porphyrins are tetrapyrrolic macrocyclic ligands known for their affinity towards neoplastic tissues and once radiolabeled with a suitable diagnostic radioisotope could potentially be used for the imaging of tumorous lesions. In the present study, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54b0294e03190ee7fbb1d4dc14f20c34
https://doi.org/10.1039/c8md00559a
https://doi.org/10.1039/c8md00559a